Last reviewed · How we verify
Houyanqing Oral Liquid
Houyanqing Oral Liquid is a traditional Chinese medicine formulation that modulates immune function and inflammatory pathways to treat respiratory and related conditions.
Houyanqing Oral Liquid is a traditional Chinese medicine formulation that modulates immune function and inflammatory pathways to treat respiratory and related conditions. Used for Cough and phlegm-related respiratory conditions, Chronic respiratory symptoms (Phase 3 indication under investigation).
At a glance
| Generic name | Houyanqing Oral Liquid |
|---|---|
| Sponsor | Sun Yat-sen University |
| Modality | Small molecule |
| Therapeutic area | Respiratory / Immunology |
| Phase | Phase 3 |
Mechanism of action
The exact molecular targets are not well-characterized in Western pharmacological literature, as this is a multi-component herbal preparation. It is believed to work through multiple bioactive compounds that collectively enhance immune response and reduce inflammation in respiratory tissues. The formulation is used primarily in Chinese medicine practice for treating cough, phlegm, and respiratory symptoms.
Approved indications
- Cough and phlegm-related respiratory conditions
- Chronic respiratory symptoms (Phase 3 indication under investigation)
Common side effects
Key clinical trials
- Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Houyanqing Oral Liquid CI brief — competitive landscape report
- Houyanqing Oral Liquid updates RSS · CI watch RSS
- Sun Yat-sen University portfolio CI